ATE224456T1 - Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft - Google Patents

Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft

Info

Publication number
ATE224456T1
ATE224456T1 AT97944986T AT97944986T ATE224456T1 AT E224456 T1 ATE224456 T1 AT E224456T1 AT 97944986 T AT97944986 T AT 97944986T AT 97944986 T AT97944986 T AT 97944986T AT E224456 T1 ATE224456 T1 AT E224456T1
Authority
AT
Austria
Prior art keywords
diabetic retinopathy
risk
detection
genetic predisposition
vision loss
Prior art date
Application number
AT97944986T
Other languages
English (en)
Inventor
Gordon Duff
Ian Rennie
Robert Richardson
Original Assignee
Gordon Duff
Ian Rennie
Robert Richardson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gordon Duff, Ian Rennie, Robert Richardson filed Critical Gordon Duff
Application granted granted Critical
Publication of ATE224456T1 publication Critical patent/ATE224456T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Eye Examination Apparatus (AREA)
  • Catching Or Destruction (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97944986T 1996-10-10 1997-10-09 Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft ATE224456T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9621129.7A GB9621129D0 (en) 1996-10-10 1996-10-10 Detecting genetic predisposition to sight-threatening diabetic retinopathy
PCT/GB1997/002790 WO1998015653A1 (en) 1996-10-10 1997-10-09 Detecting genetic predisposition to sight-threatening diabetic retinopathy

Publications (1)

Publication Number Publication Date
ATE224456T1 true ATE224456T1 (de) 2002-10-15

Family

ID=10801212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97944986T ATE224456T1 (de) 1996-10-10 1997-10-09 Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft

Country Status (12)

Country Link
US (1) US6713253B1 (de)
EP (1) EP0950113B1 (de)
AT (1) ATE224456T1 (de)
AU (1) AU742957B2 (de)
CA (1) CA2267155C (de)
DE (1) DE69715669T2 (de)
DK (1) DK0950113T3 (de)
ES (1) ES2186926T3 (de)
GB (1) GB9621129D0 (de)
IL (1) IL129390A (de)
WO (1) WO1998015653A1 (de)
ZA (1) ZA979071B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720141B1 (en) * 1999-11-01 2004-04-13 Interleukin Genetics, Inc. Diagnostics and therapeutics for restenosis
US6524795B1 (en) 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
GB9711040D0 (en) 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
CA2328955C (en) * 1998-04-21 2008-03-18 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
US6733967B1 (en) 1998-04-21 2004-05-11 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
US6251598B1 (en) * 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
EP1252895A4 (de) * 2000-01-31 2003-04-16 Santen Pharmaceutical Co Ltd Heilmittel für ophthalmologische zustände
GB0009294D0 (en) 2000-04-15 2000-05-31 Sec Dep For The Home Departmen Improvements in and relating to analysis of DNA samples
KR101019131B1 (ko) * 2001-11-19 2011-03-07 인터레우킨 제네틱스, 인코포레이티드 염증성 질환 및 감염성 질환에 대한 감수성 및 전사에영향을 미치는 인터루킨-1 좌의 기능적 다형성
JP2005529585A (ja) 2002-01-25 2005-10-06 インターリューキン ジェネティックス インコーポレイテッド Ｉｌ−１遺伝子群ならびに関連する炎症性多型およびハプロタイプ
CN1711361A (zh) * 2002-10-15 2005-12-21 诺瓦提斯公司 预测药物治疗副效应水肿的方法
CN1863928A (zh) * 2003-08-08 2006-11-15 英特利金遗传学有限公司 骨质疏松的诊断和治疗
GB0417763D0 (en) * 2004-07-09 2004-09-08 Sec Dep For The Home Departmen Improvements in and relating to the investigation of dna samples
WO2007050794A2 (en) 2005-10-25 2007-05-03 Interleuken Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
US20090053816A1 (en) * 2006-03-24 2009-02-26 University Of Louisville Research Foundation, Inc. Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders
WO2007113490A1 (en) * 2006-04-03 2007-10-11 Forensic Science Service Limited Improvements in and relating to analysis of mixed source dna profiles
US20110092446A1 (en) * 2007-07-20 2011-04-21 Cedric Francois Compositions and methods for treatment of trauma
ES2337115B2 (es) * 2007-09-26 2011-01-24 Universidade De Santiago De Compostela Metodo para la deteccion del riesgo de desarrollar vitreorretinopatiaproliferante (vrp).
WO2009061506A2 (en) * 2007-11-08 2009-05-14 Interleukin Genetics, Inc. Diagnostics for aging-related dermatologic disorders
CA2723247A1 (en) * 2008-05-02 2009-11-05 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
US20100098775A1 (en) * 2008-05-02 2010-04-22 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
WO2017123696A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
EP3980561A1 (de) 2019-06-06 2022-04-13 Sitokine Limited Zusammensetzungen und verfahren zur behandlung von lungen-, kolorektal- und brustkrebs
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2614853B2 (ja) 1985-06-14 1997-05-28 ジェネティック システムズ コーポレイション 増加した危機の糖尿病に関連する対立遺伝子を同定するための方法
US5039606A (en) 1987-10-29 1991-08-13 Virginia Mason Research Center Diagnostic probe for diabetes type I predisposition
US5686246A (en) 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5698399A (en) 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis

Also Published As

Publication number Publication date
IL129390A (en) 2002-05-23
WO1998015653A1 (en) 1998-04-16
IL129390A0 (en) 2000-02-17
AU742957B2 (en) 2002-01-17
CA2267155C (en) 2003-07-08
DE69715669T2 (de) 2003-09-18
US6713253B1 (en) 2004-03-30
EP0950113B1 (de) 2002-09-18
GB9621129D0 (en) 1996-11-27
ES2186926T3 (es) 2003-05-16
EP0950113A1 (de) 1999-10-20
ZA979071B (en) 1998-07-08
DK0950113T3 (da) 2003-01-27
CA2267155A1 (en) 1998-04-16
DE69715669D1 (de) 2002-10-24
AU4631197A (en) 1998-05-05

Similar Documents

Publication Publication Date Title
DE69715669D1 (de) Detektion einer genetischen prädisposition für diabetische retinopathie mit dem risiko des verlusts der sehkraft
WO2000004187A3 (en) Methods and kits for diagnosing and determination of the predisposition of diseases
ATE247718T1 (de) Erkennung einer genetischen prädisposition fur osteoporose
DE69029018D1 (de) Verfahren zum Nachweis von benachbarten und entfernt lokalisierten Allelen als Haplotypen mittels Intronsequenzanalyse
FI20050011A7 (fi) Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
MY132156A (en) Detecting genetic predisposition to periodontal disease
WO1998028444A3 (en) Customized oligonucleotide microchips as multiple biosensors
ATE419380T1 (de) Bestimmung des kollagen genotyps
EP0398709A3 (de) Genetische Diagnose von Torsion-Dystonia
WO2001004349A3 (en) Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
ATE261497T1 (de) Diagnostisches verfahren und gerät
WO2002053018A3 (en) Method of detecting polymorphisms associated with breast carcinoma in mhc genes
WO2003014879A3 (en) System and method for identifying a genetic risk factor for a disease or pathology
WO2002046459A3 (en) Method for the determination of at least one functional polymorphism in the nucleotide sequence of a preselected candidate gene and its applications
CN106701924A (zh) 单核苷酸多态性rs55882956在筛查麻风患者中的应用
WO1999040220A3 (en) Method of screening therapeutic agents
DE69535023D1 (de) Ein diagnose-verfahren und ein testsatz für die bestimmung des kell blutgruppln-nenotyps
CA2263712A1 (en) Methods for diagnosing and assessing a predisposition to bipolar affective disorder
WO2003023063A1 (en) Method of judging onset risk of diabetes
Johnson et al. Segregation of linked probes to myotonic dystrophy in a family demonstrating that 152 and APOC2 are on the same side of DM on 19q
WO2002090585A3 (en) Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
WO1999014374A3 (en) Methods for determining genetic susceptibility to diabetic nephropathy
DE69834831D1 (de) Gen, das im zusammenhang steht mit gemütskrankheiten
WO2001020337A8 (en) Genetic testing for periodontitis based on cathepsin c

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0950113

Country of ref document: EP

REN Ceased due to non-payment of the annual fee